Over the last year, the Family PACT Program has added several new benefits. These include three new contraceptive methods, a diagnostic test for Mycoplasma genitalium, and modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines. In this webinar, a description of the new benefits will be provided and the Family PACT policies that relate to their utilization will be discussed. There will be ample time to ask questions regarding these and other Family PACT benefits.
Learning Objectives:
Describe and explain the three new contraceptive methods and explain how to discuss the advantages and disadvantages of each with Family PACT clients
List three circumstances when the use of the diagnostic test for Mycoplasma genitalium is clinically indicated
Describe four modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines
Speakers:
Michael Policar, MD, MPH Professor Emeritus, UCSF Senior Medical Advisor, CAPTC and California OFP Clinical Fellow, NFPRHA
Home
Training Talking with Family Planning Clients About COVID-19 Vaccination
Talking with Family Planning Clients About COVID-19 Vaccination
November 18, 2021
This webinar event is a collaboration between The California Department of Health Care Services Office of Family Planning, the California Prevention Training Center, the California Department of Public Health, and “#ThisIsOurShot” Program.
Please join two OBGYNs, Dr. LaTanya Hines and Dr. Michael Policar, for a webinar training on how to effectively communicate with your clients about COVID-19 vaccination, including overall safety, safety and efficacy during pregnancy and post-partum lactation, and the evidence regarding COVID-19 vaccination and future fertility.
Learning Objectives:
Why it’s important for clinicians and family planning counselors to discuss COVID-19 vaccination with clients who are seen for family planning services
Key messages that address common concerns of reproductive-aged individuals about the COVID-19 vaccine, especially among people who are considering becoming pregnant, are currently pregnant, and those who are lactating
An evidence-based methodology to tackle tough vaccine conversations and get to “yes”
Presenters:
LaTanya R. Hines, MD, FACOG Assistant PIC Baldwin Hills Crenshaw MOB Assistant Clinical Professor Obstetrics and Gynecology Kaiser Permanente Bernard J. Tyson School of Medicine
Home
Training 2021 Implementing the CDC STI Treatment Guidelines: A Conversation for Family PACT Providers
2021 Implementing the CDC STI Treatment Guidelines: A Conversation for Family PACT Providers
The long-awaited 2021 CDC Sexually Transmitted Infections Treatment Guidelines were published in MMWR on July 22, 2021. This webinar will focus on significant changes from the 2015 CDC STD Treatment Guidelines, including updated guidelines for the screening, diagnosis and treatment of gonorrhea, chlamydia, syphilis, pelvic inflammatory disease, genital herpes, Mycoplasma genitalium, and vaginal trichomoniasis. To assist health care providers in obtaining a sexual history, the updated “Five P’s” approach will be reviewed. In addition, current Family PACT benefits for each type of sexually transmitted infection discussed in the program will be explained.
Learning Objectives:
List 3 examples of sexual history questions for each the “Five P’s” of sexual history taking
Explain why the treatment guidelines for both chlamydia and gonorrhea genital tract infections were updated in the 2021 Guidelines
List the indications for obtaining chlamydia and gonorrhea samples from the anus and the oropharynx
Describe the consequences of Mycoplasma genitalium genital infection in males and females
List 2 updates in the 2021 Guidelines regarding vaginal trichomoniasis
Home
Training STD Expert Hour Webinar – New Frontiers in STI/HIV Prevention and Family Planning: The promise of Multipurpose Prevention Technologies
STD Expert Hour Webinar – New Frontiers in STI/HIV Prevention and Family Planning: The promise of Multipurpose Prevention Technologies
Wednesday, June 23, 2021
Presented by Bethany Young Holt, PhD, MPH
Learn about the latest developments in the field of Multipurpose Prevention Technologies (MPTs), products that provide contraception along with protection from STIs and/or HIV.
The origins of MPTs and the current research/development pipeline will also be discussed.
Learning Objectives:
Provide evidence of the need for products that simultaneously address multiple health risks, such as HIV, other STIs, and unplanned pregnancy
Introduce and implement Multipurpose Prevention Technologies (MPTs) and the product candidates currently in development for prevention of HIV, other STIs and/or unintended pregnancies
Describe the Initiative for MPTs (IMPT) and its publicly-available tools for tracking the MPT product development pipeline, while summarizing the current pipeline profile, recent scientific breakthroughs, and the potential impact of MPTs for women around the world
Outline next steps for key stakeholders in STI prevention and related health fields, with a focus on tangible priority actions that will help bring MPTs to the hands of end-users
The CPT rules for the use of problem-oriented E/M office visit codes changed significantly on January 1, 2021. Since then, office visits are coded based on levels of medical decision-making or “total time” and the prior rules for using the “three key components” no longer apply. Consequently, Family PACT E/M coding policies were updated in February 2021, as well as the publication of a new policy on coding and billing for counselor services.
Learning Objectives:
List at least six activities that can be counted in the “total time” of a visit when computing E/M level
List each of the 3 elements used in medical decision-making, and give examples of each
Describe the Family PACT policy for coding for a clinician visit and counselor services on the same date of service
Guidance and procedures from the American College of Obstetricians and Gynecologists (ACOG) about the COVID-19 vaccine for pregnant and lactating individuals.
An overview of and frequently asked questions about emergency contraception (EC). EC represents a “last chance” to prevent unintended pregnancy. Categories of EC are emergency contraceptive pills (ECPs), including ulipristal acetate (UPA) and levonorgestrel (LNG) and the copper intrauterine device (IUD).
Holding an IUD birth control copper coil device in hand, used for contraception –
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.AcceptDisable
